中草药对治疗癌症恶病质动物模型有效性的系统性回顾

A systematic review of herbal medicines for the treatment of cancer cachexia in animal models 中草药对治疗癌症恶病质动物模型有效性的系统性回顾 1 first-author 2 3 4 2 corresp ‡Corresponding Author ‡Corresponding Author †E-mail:drmslee@gmail.commslee@kiom.re.kr †E-mail:drmslee@gmail.commslee@kiom.re.kr drmslee@gmail.com Liver and Immunology Research Center, Oriental College, Daejeon University, Daejeon 34020, Republic of Korea Liver and Immunology Research Center, Oriental College, Daejeon University, Daejeon 34020, Republic of Korea Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China Department of Korean Internal Medicine, School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea Department of Korean Internal Medicine, School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea Objective: 2 The aim of this study is to summarize preclinical studies on herbal medicines used to treat cancer cachexia and its underlying mechanisms. Methods: 2 We searched four representing databases, including PubMed, EMBASE, the Allied and Complementary Medicine Database, and the Web of Science up to December 2016. Randomized animal studies were included if the effects of any herbal medicine were tested on cancer cachexia. The methodological quality was evaluated by the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMARADE) checklist. Results: 2 A total of fourteen herbal medicines and their compounds were identified, including Coptidis Rhizoma, berberine, Bing De Ling, curcumin, Qing-Shu-Yi-Qi-Tang, Scutellaria baicalensis , Hochuekkito, Rikkunshito, hesperidin, atractylodin, Sipjeondaebo-tang, Sosiho-tang, Anemarrhena Rhizoma, and Phellodendri Cortex. All the herbal medicines, except curcumin, have been shown to ameliorate the symptoms of cancer cachexia through anti-inflammation, regulation of the neuroendocrine pathway, and modulation of the ubiquitin proteasome system or protein synthesis. Conclusions: 2 This study showed that herbal medicines might be a useful approach for treating cancer cachexia. However, more detailed experimental studies on the molecular mechanisms and active compounds are needed. 本综述总结利用中草药治疗癌症恶病质的临床前研究及其潜在的机制,是首个针对中草药治疗癌症恶病质动物模型成效进行系统性回顾评价的研究.本文通过检索PubMed、EMBASE、Allied and Complementary Medicine Database以及Web of Science四大代表性的资料库(检索时间至2016年12月),就中草药治疗癌症恶病质的随机对照动物试验进行系统性回顾分析,并采用CAMARADE评分清单进行质量评价.分析结果显示:在十四项中草药及其化合物中,除了姜黄素外其他如黄连、黄连素、病得灵、清暑益气汤、黄芩、补中益气汤、六君子汤、橙皮苷、苍术呋喃烃、十全大补汤、小柴胡汤、知母及黄柏等都已被证实可以通过抗炎、调节神经内分泌途径、调节泛素蛋白酶体系统或蛋白质合成来改善癌症恶病质的症状.因此,利用中草药治疗癌症恶病质是一种有效的方法.然而该结论尚需要有更详细的分子机制和活性化合物的实验研究验证. Cancer Cachexia Herbal medicine Traditional East Asian medicine systematic review 癌症 恶病质 中草药 传统东亚医学系统性回顾 Introduction 1 Cachexia is a complex syndrome that frequently occurs in advanced cancer patients. The incidence of cancer cachexia depends on the cancer type, with approximately 30% to 80% of advanced cancer patients suffering from cachexia (Mantovani et al., 2001 2001 ; Teunissen et al., 2007 2007 ). Anorexia, weight loss, and the loss of adipose tissue and skeletal muscle are the main symptoms of cancer cachexia. Various definitions of cancer cachexia have been proposed (Evans et al., 2008 2008 ; Muscaritoli et al., 2010 2010 ; Fearon et al., 2011 2011 ; Blum et al., 2014 2014 ), but the present consensus defines “cancer cachexia as a multifactorial syndrome characterized by the ongoing loss of skeletal muscle mass with or without the loss of fat mass that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment” (Muscaritoli et al., 2010 2010 ; Fearon et al., 2011 2011 ). Although the underlying mechanisms have not been fully determined, cancer cachexia occurs because of a protein and energy imbalance induced by an abnormal metabolism and reduced food intake (Fearon et al., 2011 2011 ; Mendes et al., 2015 2015 ; Penet and Bhujwalla, 2015 2015 ). Cancer cachexia causes many clinical problems including lowered activity, quality of life, and response to chemotherapy (Brown, 2002 2002 ). Additionally, it is associated with a poor survival rate and accounts for approximately 20% of cancer deaths (Tisdale, 1997 1997 ). Therefore, the management of cancer cachexia is an important issue. Many therapeutic approaches for cancer cachexia have been investigated in preclinical studies and clinical trials and include appetite stimulants, anti-inflammatory agents, ghrelin, nutritional support, and anabolics (Penet and Bhujwalla, 2015 2015 ; von Haehling and Anker, 2015 2015 ). Megestrol acetate (MA), known to improve the appetite through neuropeptide Y (NPY) and to down-regulate pro-inflammatory cytokines, is an approved drug for cancer cachexia in the United States and several European nations (Argilés et al., 2013 2013 ). Recent randomized controlled trials and a systematic review showed significant improvements in appetite and weight gain with this treatment (Pascual López et al., 2004 2004 ; Lesniak et al., 2008 2008 ; Wen et al., 2012 2012 ). In addition, L -carnitine and melatonin have been shown to improve anorexia both in vivo and in randomized controlled trials (Raghavendra and Kulkarni, 2000 2000 ; Del Fabbro et al., 2013a 2013a ; von Haehling and Anker, 2015 2015 ). For anti-inflammatory agents, thalidomide and pentoxyphylline have been reported to have anti-inflammatory properties (Davis et al., 2012 2012 ; Yennurajalingam et al., 2012 2012 ; Rattanasompattikul et al., 2013 2013 ). Recently, a monoclonal antibody that targets interleukin-α was investigated in phase I clinical trials (Hong et al., 2014 2014 ). The administration of ghrelin or its agonist, anamorelin, has been shown to increase food intake and prevent weight loss (Neary et al., 2004 2004 ; Strasser et al., 2008 2008 ; Lenk et al., 2013 2013 ). In addition, anabolics such as enbosarm and testosterone have been shown to have therapeutic effects on cachexia (Del Fabbro et al., 2013b 2013b ; Dobs et al., 2013 2013 ; Crawford et al., 2016 2016 ). Oriential medicine uses herbal medicines for treating a variety of diseases. Therefore, many studies have been conducted to explore the use of herbal medicines for treating diseases, including cancer cachexia. The therapeutic mechanisms of herbal medicines and their active compounds have been gradually uncovered and interpreted through in vivo studies. The aim of this study is to summarize such preclinical studies for the treatment of cancer cachexia and the underlying mechanisms. Methods 1 Search strategy 2 Four electronic databases (PubMed, EMBASE, the Allied and Complementary Medicine Database (AMED), and the Web of Science) were searched with the following search terms (established by discussion with oncologists and experts in this field): ((cancer or oncolog* or neoplasm* or malignan* or tumor or tumour or carcinoma* or adenocarcinoma* or osteosarcoma* or sarcoma* or leukemi* or lymphoma* or teratoma* or metastat*) and (cachexia* or cachectic* or weight loss or loss of weight or underweight or malnutrition or wasting syndrome or anorexia* or muscle atrophy or sarcopenia)) and (traditional Korean medicine or traditional Chinese medicine or traditional oriental medicine or Kampo medicine or herb or herbal or herbs or decoction* or botanic*). Eligibility criteria 2 We included in vivo experimental studies using cachectic animal models induced by cancer cell implementation that administered interventions including herbal medicines or their compounds. There was no limitation on the number, administration method, dosage, or duration of treatment. We also included articles with the full text written in English. We excluded experimental studies using in vitro models only or cachectic animal models not induced with cancer cells. We also excluded studies without appropriate control groups. Data extraction 2 We extracted the following information from the articles: the authors, year of publication, herbal medicines including their compositions or active compounds, drug dosage, animal species and number, the type of implanted cancer cells, and outcome measurements. The primary outcomes were biomarkers associated with cancer cachexia. The secondary outcomes were changes in the cachectic symptoms such as weight loss, muscle atrophy, fat depletion, and poor intake. The third outcomes were changes in the tumor size and survival. Assessment of methodological quality and data analyses 2 The methodological quality of the included studies was evaluated by seven items based on the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMARADE) checklist and the assessment tool of other systematic reviews in animal models. The seven items consisted of: (1) the randomized allocation of animals to the experimental group; (2) intervention allocation concealment; (3) blinded assessment of the outcome; (4) a statement of sample size calculation; (5) a statement of the number of excluded animals and the reason; (6) a statement of compliance with regulatory requirements; and (7) a statement of possible conflicts of interest. The evaluated domains were assessed as “yes” or “no” according to the criteria. Results 1 Characteristics of the included studies 2 We identified 518 articles from the four electronic databases. After excluding duplicate studies and articles that did not meet the inclusion criteria on the basis of reading the title and abstract, the full texts of 25 articles were retrieved and evaluated. Of the 25 articles, 12 were excluded because they did not report in vivo research and/or were duplicates. As a result, we selected 13 in vivo studies for this study (Iizuka et al., 2000 2000 , 2002 2002 ; Xu et al., 2005 2005 ; Beckett et al., 2008 2008 ; Fujitsuka et al., 2011 2011 ; Chou et al., 2012 2012 ; Wang et al., 2012 2012 ; Yae et al., 2012 2012 ; Choi et al., 2014 2014 ; Terawaki et al., 2014 2014 ; Ohbuchi et al., 2015 2015 ; Kim et al., 2016 2016 ; Zhuang et al., 2016 2016 ) (Fig. 1 1 ). The characteristics of the included studies are summarized in Table 1 1 . Nine studies were performed with mice and four studies used rats. A total of eight techniques were used for cancer cachectic models. Wistar rats with AH-130 hepatoma cells and C57BL/6 mice with Lewis lung carcinoma were used the most frequently and were each used in three studies. A total of fourteen herbal medicines or their compounds were explored. Of them, Rikkunshito (RKT) was investigated the most and was used in three trials, and Qing-Shu-Yi-Qi-Tang (QSYQT) was studied the second most frequently, in two studies. ↓: significantly decrease as the compared with the control group; ↑: significantly increase as compared with the control group; n.s.: no significant difference; IL: interleukin; 5-FU: 5-fluorouracil; QSYQT: Qing-Shu-Yi-Qi-Tang; TNF-α: tumor necrosis factor-α; NF-κB: nuclear factor-κB; MCP-1: monocyte chemoattractant protein-1; MuRF-1: muscle RING finger protein-1; CRF: corticotropin-releasing factor; NPY: neuropeptide Y; IFN-γ: interferon-γ; PYY: peptide YY; GLP: glucagon-like peptide; IGF-1: insulin-like growth factor-1; p-AKT: phosphorylated Akt; LC3B: light chain 3B; FOXO3: forkhead box O3. No detailed information for herbal formulas Author (year) Animal model, implanted cancer cell Interventions (dose) Control Outcome measurements and results Iizuka et al. ( 2000 2000 ) BALB/c nude mice, YES-2 cell Coptidis Rhizoma (water extraction, 10 mg/g in diet) Untreated IL-6 in tumor (↓) Weight loss (↓), food intake (n.s.) Tumor size (n.s.) Iizuka et al. ( 2002 2002 ) BALB/c mice, colon 26/clone 20 cell Coptidis Rhizoma (water extraction, 10 or 20 mg/g in diet) Untreated IL-6 in serum and tumor (↓), IL-6 in liver and spleen (n.s.) Weight loss (↓), loss of gastrocnemius muscle (↓), loss of epididymal adipose tissue (↓), food intake (n.s.) Tumor size (n.s.) Berberine (1, 2, and 4 mg/g in diet) Untreated IL-6 in serum and tumor (↓), IL-6 in liver and spleen (n.s.) Weight loss (↓), loss of gastrocnemius muscle (↓), loss of epididymal adipose tissue (↓), food intake (n.s.) Tumor size (n.s.) Xu et al. ( 2005 2005 ) BALB/c mice, CT26 cell 5-FU plus Bing De Ling * * (water extraction, 0.121 g/mL of water) 5-FU Weight loss (↓) Tumor size (↓), survival rates (↑) Beckett et al. ( 2008 2008 ) C57BL/6 mice, Lewis lung carcinoma Curcumin (powder, 150 mg/kg in diet) Untreated Weight loss (n.s.), loss of muscle weight (n.s.), food intake (n.s.) Tumor size (n.s.) C57BL/6 mice, B16 melanoma tumor cell Curcumin (powder, 150 mg/kg in diet) Untreated Weight loss (n.s.), loss of muscle weight (n.s.), food intake (n.s.) Tumor size (↓) Chou et al. ( 2012 2012 ) C57BL/6 mice, Lewis lung carcinoma cell QSYQT * * (water extraction, 10 mL/kg in water) Untreated IL-1β (↓), IL-6 (↓), and TNF-α (↓) in serum, NF-κB mRNA (↓) in spleen Weight loss (↓), food intake (n.s.) Tumor size (n.s.) Wang et al. ( 2012 2012 ) C57BL/6 mice, Lewis lung carcinoma cell 5-FU plus QSYQT * * with Scutellaria baicalensis (1.5 and 3.0 mg/g) 5-FU IL-6 (n.s.), TNF-α (n.s.), and MCP-1 (↓) in serum, NF-κB mRNA (n.s.), and MuRF-1 mRNA (↓) in gastrocnemius muscle Weight loss (↓), loss of the gastrocnemius muscle (↓) Tumor size (↓) Yae et al. ( 2012 2012 ) BALB/c mice, colon 26/clone 20 cell Hochuekkito * * (water extraction, 1.2 g/kg in diet) Untreated IL-6 (↓) in serum and marcrophage surrounding tumor, IL-6 (n.s.) in tumor cells, TNF-α (n.s.) in serum Weight loss (carcass weight) (↓), loss of the gastrocnemius muscle and fat tissue (↓), food intake (↑) Tumor size (n.s.) Fujitsuka et al. ( 2011 2011 ) Wistar rats, AH-130 hepatoma cell Rikkunshito * * (powdered extract, 125, 250, 500, and 1000 mg/kg) Untreated or cisplatin Hypothalamic CRF (↓), Ca 2+ in NPY neurons (↑) Food intake (↑) Median survival (↑) Atractylodin Median survival (↑) Terawaki et al. ( 2014 2014 ) F344/NJcl-rnu/rnu rats, 85As2 cells (human stomach cancer cell) Rikkunshito * * (powdered extract, 1000 mg/kg) Untreated Weight loss (↓), loss of total muscle weight (↓), loss of fat free mass (↓), loss of total fat (↓), food and water intake (↑) Ohbuchi et al. (2015) Wistar rats, AH-130 hepatoma cell Rikkunshito * * (powdered extract, 1000 mg/kg) Untreated Glucarate (↑) in serum Glucarate (metabolite) (2, 6, and 18 mmol/kg) Untreated IFN-γ (↓), TNF-α (n.s.), and IL-10 (n.s.) in plasma Weight loss (↓), loss of gastrocnemius muscle weight (↓) Choi et al. (2014) Wistar rats, AH-130 hepatoma cell Sipjeondaebo-tang * * (water extraction, 6.784, 67.84, and 678.4 mg/kg in water) Untreated TNF-α (n.s.), IL-6 (↓), MCP-1 (↓), PYY (↓), GLP-1 (↓), active ghrelin (n.s.), and leptin (n.s.) in serum Weight loss (↓), loss of muscle weight (↓), food intake (↑) Kim et al. (2016) BALB/c mice, CT-26 cell Sosiho-tang * * (50 and 100 mg/kg) Untreated IL-6 (↓), TNF-α (n.s.), and IL-1β (n.s.) in serum Weight loss (↓), loss of gastrocnemius muscle weight (↓), loss of epididymal fat (↓) Tumor size (↓) Zhuang et al. (2016) C57BL/6 mice, C26 colon adenocarcinoma cell Anemarrhena Rhizoma and Phellodendri Cortex (50% ethanol extraction, 104 mg/kg) Untreated IL-6 (↓), TNF-α (↓), and IGF-1 (↑) in serum and gastrocnemius muscle, atrogin-1 mRNA (↓) and MuRF-1 mRNA (↓), p-AKT (↑), LC3B (↑), Sirt1 (↑), and FOXO3 (↓) in gastrocnemius muscle Weight loss (↓), loss of gastrocnemius muscle weight (↓) Tumor size (n.s.), survival rate (↑) As shown in Table 2 2 , only two studies reported that they were randomized. None of the studies reported allocation concealment, blinded assessment of the outcome, sample size calculations, or the number of excluded animals. Nine studies mentioned compliance with regulatory requirements. Additionally, eight studies reported possible conflicts of interests. Regarding an overall score for each item, one study was scored “yes” in three of seven items, eight studies were scored “yes” for one of the seven items, and four studies scored “yes” for two of the seven items. Y: yes; N: no Author (year) Randomized allocation Allocation concealment Blinded assessment of outcome Sample size calculation Number of excluded animal and its reason Compliance with regulatory requirements Possible conflicts of interest Iizuka et al. ( 2000 2000 ) N N N N N Y N Iizuka et al. ( 2002 2002 ) N N N N N Y N Xu et al. ( 2005 2005 ) N N N N N Y N Beckett et al. ( 2008 2008 ) N N N N N Y N Chou et al. ( 2012 2012 ) N N N N N N Y Wang et al. ( 2012 2012 ) N N N N N N Y Yae et al. ( 2012 2012 ) Y N N N N N Y Fujitsuka et al. ( 2011 2011 ) N N N N N N Y Terawaki et al. ( 2014 2014 ) N N N N N Y Y Ohbuchi et al. ( 2015 2015 ) N N N N N Y Y Choi et al. ( 2014 2014 ) Y N N N N Y Y Kim et al. ( 2016 2016 ) N N N N N Y N Zhuang et al. ( 2016 2016 ) N N N N N Y Y Herbal medicines for the treatment of cancer cachexia 2 3.2.1 Coptidis Rhizoma and berberine Coptidis Rhizoma, the root of Coptis chinensis Franchet, is a popular herbal medicine and is commonly used for diverse diseases, especially inflammation-related diseases and digestive tract ulcers (Feng et al., 2008 2008 ; Choi et al., 2013 2013 ; Jang et al., 2013 2013 ). Berberine, a major compound of Coptidis Rhizoma, has been shown to have positive effects on metabolic syndrome, diabetes, congestive heart failure, diarrhea, and cancer in preclinical and clinical studies (Kumar et al., 2015 2015 ; Wang et al., 2015 2015 ). Iizuka et al. ( 2000 2000 ) demonstrated that the oral administration of Coptidis Rhizoma to nude mice implanted with YES-2 cells significantly attenuated weight loss without a change in food intake or tumor growth and lowered the tumor interleukin-6 (IL-6) levels. Additionally, the authors reported that the treatment of YES-2 cells with berberine reduced the IL-6 mRNA expression of YES-2 cells in vitro. These observations demonstrate that Coptidis Rhizoma might have an anticachectic effect on esophageal cancer, and an effect was associated with berberine via the downregulation of tumor IL-6 production. This phenomenon was reconfirmed in mice bearing colon 26/clone 20 carcinoma cells (Iizuka et al., 2002 2002 ). 3.2.2 Bing De Ling Bing De Ling, a mixture of seven herbs, Astragalus membranaceus , Rheum palmatum , Atractylodes macrocephala , Isatis tinctoria , Scutellaria baicalensis , Cornus officinalis , and Dryopteris crassirhizoma , has been prescribed for common colds, influenza, chronic fatigue syndrome, herpes simplex, and chemotherapy-induced toxicities (Xu et al., 2005 2005 ). Bing De Ling was reported to respond to increased immunologic activity and anti-tumor activity because of the activation of p53 (Niu et al., 2000 2000 ; Zhang et al., 2010 2010 ). Xu et al. ( 2005 2005 ) demonstrated that the oral administration of Bing De Ling to CT26 mouse colon cancer cell-bearing mice via 5-fluorouracil (5-FU) chemotherapy significantly enhanced 5-FU-induced tumor growth inhibition. The oral administration of Bing De Ling also enhanced the survival rates and reduced weight loss in tumor-free mice receiving 5-FU compared to tumor-free mice that received 5-FU alone. This study showed that Bing De Ling enhances the antitumor responses of 5-FU and ameliorates its side effects. 3.2.3 Curcumin Curcumin is the active ingredient isolated from the rhizome of Curcuma longa Linné, with usage as a treatment for inflammatory conditions in East and Southeast Asia. Curcumin is shown to be a highly pleiotropic molecule that interacts with numerous inflammatory molecular targets. Thousands of in vitro and in vivo studies have explored the molecular basis of curcumin’s attributed antioxidant, anti-inflammatory, antibacterial, antiapoptosis, and anti-cancer activity. In addition, hundreds of clinical trials have investigated the effects of curcumin in various chronic diseases, including diabetes, cancers, cardiovascular, neurological and psychological diseases (Naksuriya et al., 2014 2014 ; Devassy et al., 2015 2015 ; Ghosh et al., 2015 2015 ; He et al., 2015 2015 ; Shanmugam et al., 2015 2015 ). Beckett et al. ( 2008 2008 ) demonstrated that curcumin for Lewis lung carcinoma-or B16 melanoma-bearing mice reduced the tumor mass in mice with B16 melanoma without reducing splenomegaly or preserving body weight or muscle mass in either model. This study showed that curcumin may not be beneficial for treating cancer cachexia. However, the evidence of its antitumor effects in animal models suggested that clinical trials of curcumin for cancer patients would be warranted. 3.2.4 Qing-Shu-Yi-Qi-Tang and S . baicalensis QSYQT, composed of Astragalus membranaceus Bunge, Panax ginseng C. A. Meyer, Atractylodes chinensis Koidzumi, Cimicifuga foetida Linné, Atractylodes macrocephala Koidzumi, Alisma orientale Juzepzuk, Citrus reticulata Blanco, and Massa Medicata Fermentata, has been used for treating fever and pulmonary disorders in East Asia (Chou et al., 2012 2012 ). A . membranaceus , A . chinensis , and P . ginseng , the major ingredients of QSYQT, have been investigated for their immunomodulatory and anti-inflammatory activity (Cho and Leung, 2007a 2007a , 2007b 2007b ; Li et al., 2007 2007 ; Dong et al., 2008 2008 ; Agyemang et al., 2013 2013 ; Fu et al., 2014 2014 ; Li et al., 2014 2014 ; Ru et al., 2015 2015 ). Scutellariae Radix, the root of the medicinal plant S. baicalensis , has been widely used for various diseases. S . baicalensis shows many therapeutic effects, including tumor growth inhibition, apoptosis induction, and anti-angiogenesis (Li et al., 2011 2011 ; Muluye et al., 2014 2014 ; Wu et al., 2016 2016 ). Chou et al. ( 2012 2012 ) reported that the oral administration of QSYQT water extract to Lewis lung cancer cell-bearing mice significantly prevented weight loss without affecting food intake or tumor growth. Additionally, the authors reported that the levels of IL-1, IL-6, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) in the serum and nuclear factor-κB (NF-κB) expression in the spleen were significantly reduced in tumor-bearing mice treated with QSYQT. Wang et al. ( 2012 2012 ) demonstrated that the oral administration of QSYQT with S . baicalensis to Lewis lung cancer cell-bearing mice via 5-FU chemotherapy significantly regained body and muscle weights in addition to improving immune status. The authors also reported that the serum levels of monocyte chemoattractant protein-1 (MCP-1) and the expression levels of NF-κB and muscle RING finger protein-1 (MuRF-1) decreased when the herbal combination was administered. Based on these observations, it was concluded that QSYQT exerted an anti-cachectic effect on Lewis lung carcinoma-induced cachectic mice, and this effect was associated with the modulation of IL-6 production through NF-κB. Furthermore, with the combination of S. baicalensis , QSYQT ameliorated cachectic symptoms and positively stimulated anti-tumor immunity through an increased number of T lymphocytes and enhanced cytotoxicity of natural killer (NK) cells in the spleen. 3.2.5 Hochuekkito Hochuekkito, Bojungikki-tang in Korean and Bu-Zhong-Yi-Qi-Tang in Chinese, is composed of ten medicinal herbs, Astragali Radix, Atractylodis Rhizoma, Ginseng Radix, Angelicae Gigantis Radix, Bupleuri Radix, Zizyphi Fructus, Citri Unshius Pericarpium, Glycyrrhizae Radix et Rhizoma, Cimicifugae Rhizoma, and Zingiberis Rhizoma Crudus. Hochuekkito has been widely used for the treatment of general fatigue, poor appetite, spontaneous sweating, and intermittent fever in East Asia. It has a variety of biological activity including immunomodulation, anti-inflammation, and anti-cancer effects (Jeong et al., 2010 2010 ; Yao et al., 2012 2012 ; Yanagihara et al., 2013 2013 ; Lee et al., 2014 2014 ; Yang et al., 2015 2015 ). Yae et al. ( 2012 2012 ) examined the therapeutic effect of Hochuekkito in the colons of 26 adenocarcinoma cell-bearing mice. Hochuekkito significantly decreased carcass weight reduction, food and water intake, weight of the gastrocnemius muscle and fat tissue around the testes, and serum triglyceride levels. In addition, Hochuekkito treatment significantly reduced serum IL-6 expression levels in macrophages in tissues surrounding the tumor. This study showed that Hochuekkito inhibits the production of pro-inflammatory cytokines, particularly IL-6, by macrophages. 3.2.6 Rikkunshito, hesperidin, and atractylodin RKT, the traditional herbal formula of East Asia, is composed of Atractylodis Rhizoma, Ginseng Radix, Pinelliae Tuber, Poria Sclerotium, Zizyphi Fructus, Citri Unshius Pericarpium, Glycyrrhizae Radix et Rhizoma, and Zingiberis Rhizoma Crudus (Fujitsuka and Uezono, 2014 2014 ). RKT is widely used for the treatment of functional dyspepsia, gastritis, and chemotherapy-induced dyspepsia in cancer patients (Tatsuta and Iishi, 1993 1993 ; Mogami and Hattori, 2014 2014 ; Saegusa et al., 2015 2015 ). RKT enhances appetite and gastric motility by increasing endogenous ghrelin or ghrelin signal levels (Takeda et al., 2008 2008 , 2010 2010 ; Fujitsuka et al., 2009 2009 , 2011 2011 ; Saegusa et al., 2011 2011 ; Yamada et al., 2013 2013 ; Nahata et al., 2014 2014 ). Additionally, several clinical trials showed that RKT was effective in ameliorating dyspepsia, epigastric pain, and postprandial fullness. Hesperidin and atractylodin, the active compounds of RKT, are known to have antioxidant, anti-inflammatory, or antibacterial activity (Chen et al., 2012 2012 ; Iranshahi et al., 2015 2015 ; Parhiz et al., 2015 2015 ). Fujitsuka et al. ( 2011 2011 ) demonstrated that the oral administration of RKT to AH-130 hepatoma cell bearing-rats showed improved food intake and median survival. Furthermore, the oral administration of hesperidin and atractylodin also improved the median survival. In addition to these results, the authors reported that RKT suppressed the serotonin (5-HT)-corticotropin-releasing factor (CRF) neuronal pathway and sensitized the ghrelin receptor in NPY neurons in the arcuate nucleus of the hypothalamus. Terawaki et al. ( 2014 2014 ) reported that the oral administration of RKT to rats implanted with 85As2 human stomach cancer showed improved food and water intake and ameliorated the loss of body weight, fat-free mass, total body water, and muscular weight. Ohbuchi et al. ( 2015 2015 ) studied the oral administration of RKT to AH-130 hepatoma cell bearing-rats. The authors reported significant elevations of glucarate in the metabolome analysis of plasma in these animal models, and the administration of glucarate delayed weight loss, improved muscle atrophy, and reduced plasma IFN-γ level. Based on these observations, RKT ameliorates cancer cachectic symptoms via a physiologic pathway, including the 5-HT-CRF neuronal pathway, sensitized by the ghrelin receptor in NPY neurons in the arcuate nucleus of the hypothalamus, and anti-inflammatory activity is achieved by attenuating glucarate in the plasma. 3.2.7 Sipjeondaebo-tang Sipjeondaebo-tang (SJDBT), Shiquandabu-tang in Chinese and Juzentaihoto in Japanese, is composed of ten species of herbs, which are Angelica gigas Nakai, Astragalus membranaceus Bunge, Atractylodes japonica Koidzumi, Cinnamomum cassia Presl, Cnidium officinale Makino, Glycyrrhiza uralensis Fischer, Paeonia lactiflora Pallas, Panax ginseng C. A. Meyer, Poria cocos Wolf, and Rehmannia glutinosa Liboschitz ex Steudel. SJDBT is prescribed for patients suffering from anemia, fatigue, anorexia, scaly skin, and dryness of the mouth (Matsumoto et al., 2000 2000 ; Saiki, 2000 2000 ). Choi et al. ( 2014 2014 ) examined the oral administration of SJDBT in CT-26 tumor-bearing mice. The authors reported that SJDBT was more significantly effective in a treatment model where it was administered after anorexia and cachexia than in a prevention model on the basis of parameters such as muscle and whole-body weight and food intake. Moreover, SJDBT inhibited the productions of IL-6, MCP-1, peptide YY (PYY), glucagon-like peptide-1 (GLP-1) and ameliorated cancer-induced anemia. Based on these observations, the authors concluded that SJDBT might be useful for treating cancer-associated anorexia and cachexia. 3.2.8 Sosiho-tang Sosiho-tang, Xiaochaihu-tang in Chinese and Shosaikoto in Japanese, is composed of Bupleurum falcatum Linne, Pinellia ternata Breitenbach, Scutellaria baicalensis Georgi, Zizyphus jujuba Miller var. inermis Rehder, Panax ginseng C. A. Meyer, Glycyrrhiza uralensis Fischer, and Zingiber officinale Roscoe. Sosiho-tang is clinically used for the treatment of various fever diseases including the common cold and chronic hepatic diseases (Ikegami et al., 2006 2006 ; Takahashi et al., 2014 2014 ). Kim et al. ( 2016 2016 ) demonstrated that the administration of Sosiho-tang for cancer-induced cachexia in CT-26-bearing mice significantly retarded tumor growth and prevented the loss of final body weight, carcass weight, heart weight, gastrocnemius muscle, and epididymal fat compared with saline-treated control mice. Furthermore, serum IL-6 levels elevated by cancer were decreased by the administration of Sosiho-tang. The author concluded that Sosiho-tang is a safe and useful anti-cachectic therapy for cancer patients with severe weight loss. 3.2.9 Anemarrhena Rhizoma and Phellodendri Cortex Zhimu and Huangbai (ZBHP, Anemarrhena Rhizoma and Phellodendri Cortex) has been used in East Asia to treat various diseases (Ma et al., 2008 2008 ). ZBHP was previously phytochemically investigated for constituents with anti-cancer or diabetes properties among others (Tang et al., 2012 2012 ). Rrecent research has demonstrated that ZBHP could reverse muscle atrophy in streptozotocin-induced diabetic mice (Zhang et al., 2014 2014 ). Zhuang et al. ( 2016 2016 ) investigated oral administration of ZBHP to mice implanted with colon-26 adenocarcinoma. ZBHP showed significant alleviation of the tumor-free body weight reduction and cachexia-induced changes in cytokines and prolonged survival. ZBHP inhibited muscle atrophy-related genes as well as activated the insulin-like growth factor-1 (IGF-1)/Akt and autophagy signal pathways to facilitate protein synthesis. Discussion 1 Recent studies have provided a greater understanding of the molecular mechanisms and new therapeutic approaches for cancer cachexia, but cancer cachexia still requires an efficacious remedy. Herbal medicines and their compounds have been extensively reported to have anti-cachectic effects, and this has become an active research area in the treatment of cancer cachexia. In this study, we summarized the herbal medicines and their active compounds that showed anti-cachectic effects in animal studies. We identified thirteen in vivo studies through four electronic databases. As described in Table 1 1 , the majority of herbal medicines and their active compounds, except curcumin, have been shown to ameliorate symptoms of cancer cachexia, which include weight loss, poor intake, and muscle atrophy. Ten of the thirteen studies explained the anti-cachectic effects of herbal medicines through anti-inflammation. As described in the results, many studies suggested that the included herbal medicines had anti-inflammatory effects for various diseases, and it was no surprise that the majority of the studies focused on anti-inflammatory mechanisms. Coptidis Rhizoma, berberine, Bing De Ling, QSYQT, Hochuekkito, SJDBT, Sosiho-tang, and ZBHP were shown to inhibit the production of pro-inflammatory cytokines, mainly IL-6. In addition, QSYQT with S . baicalensis and SJDBT were reported to inhibit MCP-1, which is an important mediator activating transcription factors in the early inflammatory response. RKT was shown to ameliorate inflammation partly by the elevation of glucarate in the plasma. Two studies explored how herbal medicines affected the regulation of the ubiquitin proteasome system and inhibited protein synthesis. ZBHP was reported to alleviate muscle atrophy through the inhibition of atrogin-1 and MuRF-1, and the activation of the IGF-1/Akt pathway. In addition, QSYQT with S . baicalensis was shown to downregulate NF-κB and MuRF-1. These effects might be related to the herbal medicine’s anti-inflammation mechanisms, as ZBHP and S . baicalensis are known to have anti-inflammatory effects. RKT was shown to ameliorate anorexia via regulation of the neuroendocrine pathway, including the 5-HT-CRF neuronal pathway and the ghrelin receptor in NPY neurons in the ARC of the hypothalamus. Additionally, SJDBT was reported to improve anorexia via the down-modulation of gut hormones PYY and GLP-1. Based on these results, herbal medicines might represent a potential therapeutic approach for cancer cachexia as well as adjuvant therapy. However, several issues need to be addressed. First, the methodological quality of the included studies is weak. Only two of the thirteen studies reported randomization, and none of the included studies reported allocation concealment, a blinded assessment of the outcome, a sample size calculation or the number of excluded animals. Because the risk of bias could affect the observed outcome, a well-designed study is needed. Second, the molecular mechanisms of the anti-cachectic effects of some herbal medicines were studied, but the majority of herbal medicines have not been fully studied at the level of underlying mechanisms. More detailed studies about the molecular mechanisms of herbal medicines and their active compounds are necessary. Furthermore, these studies should include clinical control trials. We believe that herbal medicines are sufficiently worthy as potential therapy agents for cancer cachexia if more profound studies about the underlying mechanisms of herbal medicines with improved methodological quality are undertaken. References K Agyemang , LF Han , EW Liu , 等 . Recent advances in Astragalus membranaceus anti-diabetic research: pharmacological effects of its phytochemical constituents . Evid Based Complement Alternat Med, 2013:654643 , 2013 . DOI: 10.1155/2013/654643 http://doi.org/10.1155/2013/654643 . Recent advances in Astragalus membranaceus anti-diabetic research: pharmacological effects of its phytochemical constituents JM Argilés , A Anguera , B Stemmler . A new look at an old drug for the treatment of cancer cachexia: megestrol acetate . Clin Nutr , 2013 . 32 ( 3 ): 319 - 324 . 23395103 DOI: 10.1016/j.clnu.2013.01.004 http://doi.org/10.1016/j.clnu.2013.01.004 . A new look at an old drug for the treatment of cancer cachexia: megestrol acetate DM Beckett , K Pycha , T Berg . Effects of curcumin on tumor growth and muscle mass in a mouse model of cancer cachexia . Oncol Nurs Forum , 2008 . 35 ( 3 ): 455 - 459 . DOI: 10.1188/08.onf.455-459 http://doi.org/10.1188/08.onf.455-459 . Effects of curcumin on tumor growth and muscle mass in a mouse model of cancer cachexia D Blum , GB Stene , TS Solheim , 等 . Validation of the consensus-definition for cancer cachexia and evaluation of a classification model–a study based on data from an international multicentre project (EPCRC-CSA) . Ann Oncol , 2014 . 25 ( 8 ): 1635 - 1642 . 24562443 DOI: 10.1093/annonc/mdu086 http://doi.org/10.1093/annonc/mdu086 . Validation of the consensus-definition for cancer cachexia and evaluation of a classification model–a study based on data from an international multicentre project (EPCRC-CSA) JK Brown . A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia . Oncol Nurs Forum , 2002 . 29 ( 3 ): 517 - 532 . 11979284 DOI: 10.1188/02.ONF.517-532 http://doi.org/10.1188/02.ONF.517-532 . A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia YJ Chen , YX Wu , HX Wang , 等 . A new 9-nor-atractylodin from Atractylodes lancea and the antibacterial activity of the atractylodin derivatives . Fitoterapia , 2012 . 83 ( 1 ): 199 - 203 . 22061661 DOI: 10.1016/j.fitote.2011.10.015 http://doi.org/10.1016/j.fitote.2011.10.015 . A new 9-nor-atractylodin from Atractylodes lancea and the antibacterial activity of the atractylodin derivatives WCS Cho , KN Leung . In vitro and in vivo anti-tumor effects of Astragalus membranaceus . Cancer Lett , 2007 . 252 ( 1 ): 43 - 54 . 17223259 DOI: 10.1016/j.canlet.2006.12.001 http://doi.org/10.1016/j.canlet.2006.12.001 . In vitro and in vivo anti-tumor effects of Astragalus membranaceus WCS Cho , KN Leung . In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus . J Ethnopharmacol , 2007 . 113 ( 1 ): 132 - 141 . 17611061 DOI: 10.1016/j.jep.2007.05.020 http://doi.org/10.1016/j.jep.2007.05.020 . In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus YK Choi , KY Jung , SM Woo , 等 . Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice . Mediators Inflamm, 2014:736563 , 2014 . DOI: 10.1155/2014/736563 http://doi.org/10.1155/2014/736563 . Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice YY Choi , MH Kim , IH Cho , 等 . Inhibitory effect of Coptis chinensis on inflammation in LPS-induced endotoxemia . J Ethnopharmacol , 2013 . 149 ( 2 ): 506 - 512 . 23871807 DOI: 10.1016/j.jep.2013.07.008 http://doi.org/10.1016/j.jep.2013.07.008 . Inhibitory effect of Coptis chinensis on inflammation in LPS-induced endotoxemia YJ Chou , CY Kuo , PY Chen , 等 . Oral administration of Qing-Shu-Yi-Qi-Tang reduce lung cancer-induced cachexia in mice . Afr J Pharm Pharmacol , 2012 . 6 ( 2 ): 84 - 91 . DOI: 10.5897/AJPP11.186 http://doi.org/10.5897/AJPP11.186 . Oral administration of Qing-Shu-Yi-Qi-Tang reduce lung cancer-induced cachexia in mice J Crawford , CMM Prado , MA Johnston , 等 . Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials) . Curr Oncol Rep , 2016 . 18 ( 6 ): 37 27138015 DOI: 10.1007/s11912-016-0522-0 http://doi.org/10.1007/s11912-016-0522-0 . Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials) M Davis , W Lasheen , D Walsh , 等 . A phase II dose titration study of thalidomide for cancer-associated anorexia . J Pain Symptom Manage , 2012 . 43 ( 1 ): 78 - 86 . 21640548 DOI: 10.1016/j.jpainsymman.2011.03.007 http://doi.org/10.1016/j.jpainsymman.2011.03.007 . A phase II dose titration study of thalidomide for cancer-associated anorexia E Del Fabbro , R Dev , D Hui , 等 . Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial . J Clin Oncol , 2013 . 31 ( 10 ): 1271 - 1276 . 23439759 DOI: 10.1200/JCO.2012.43.6766 http://doi.org/10.1200/JCO.2012.43.6766 . Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial E Del Fabbro , JM Garcia , R Dev , 等 . Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial . Support Care Cancer , 2013 . 21 ( 9 ): 2599 - 2607 . 23653013 DOI: 10.1007/s00520-013-1832-5 http://doi.org/10.1007/s00520-013-1832-5 . Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial JG Devassy , ID Nwachukwu , PJH Jones . Curcumin and cancer: barriers to obtaining a health claim . Nutr Rev , 2015 . 73 ( 3 ): 155 - 165 . 26024538 DOI: 10.1093/nutrit/nuu064 http://doi.org/10.1093/nutrit/nuu064 . Curcumin and cancer: barriers to obtaining a health claim AS Dobs , RV Boccia , CC Croot , 等 . Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial . Lancet Oncol , 2013 . 14 ( 4 ): 335 - 345 . 23499390 DOI: 10.1016/S1470-2045(13)70055-X http://doi.org/10.1016/S1470-2045(13)70055-X . Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial HY Dong , LC He , M Huang , 等 . Anti-inflammatory components isolated from Atractylodes macrocephala Koidz . Nat Prod Res , 2008 . 22 ( 16 ): 1418 - 1427 . 19023804 DOI: 10.1080/14786410801931629 http://doi.org/10.1080/14786410801931629 . Anti-inflammatory components isolated from Atractylodes macrocephala Koidz WJ Evans , JE Morley , J Argilés , 等 . Cachexia: a new definition . Clin Nutr , 2008 . 27 ( 6 ): 793 - 799 . 18718696 DOI: 10.1016/j.clnu.2008.06.013 http://doi.org/10.1016/j.clnu.2008.06.013 . Cachexia: a new definition K Fearon , F Strasser , SD Anker , 等 . Definition and classification of cancer cachexia: an international consensus . Lancet Oncol , 2011 . 12 ( 5 ): 489 - 495 . 21296615 DOI: 10.1016/S1470-2045(10)70218-7 http://doi.org/10.1016/S1470-2045(10)70218-7 . Definition and classification of cancer cachexia: an international consensus YB Feng , WQ Luo , SQ Zhu . Explore new clinical application of Huanglian and corresponding compound prescriptions from their traditional use . China J Chin Mater Med , 2008 . 33 ( 10 ): 1221 - 1225 . (in Chinese) . Explore new clinical application of Huanglian and corresponding compound prescriptions from their traditional use J Fu , ZH Wang , LF Huang , 等 . Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi) . Phytother Res , 2014 . 28 ( 9 ): 1275 - 1283 . 25087616 DOI: 10.1002/ptr.5188 http://doi.org/10.1002/ptr.5188 . Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi) N Fujitsuka , Y Uezono . Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome . Front Pharmacol, 5:271 , 2014 . DOI: 10.3389/fphar.2014.00271 http://doi.org/10.3389/fphar.2014.00271 . Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome N Fujitsuka , A Asakawa , M Hayashi , 等 . Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin . Biol Psychiatry , 2009 . 65 ( 9 ): 748 - 759 . 19058784 DOI: 10.1016/j.biopsych.2008.10.031 http://doi.org/10.1016/j.biopsych.2008.10.031 . Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin N Fujitsuka , A Asakawa , Y Uezono , 等 . Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival . Transl Psychiatry , 2011 . 1 ( 7 ): e23 22832525 DOI: 10.1038/tp.2011.25 http://doi.org/10.1038/tp.2011.25 . Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival S Ghosh , S Banerjee , PC Sil . The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update . Food Chem Toxicol , 2015 . 83 111 - 124 . 26066364 DOI: 10.1016/j.fct.2015.05.022 http://doi.org/10.1016/j.fct.2015.05.022 . The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update Y He , Y Yue , X Zheng , 等 . Curcumin, inflammation, and chronic diseases: how are they linked? . Molecules , 2015 . 20 ( 5 ): 9183 - 9213 . 26007179 DOI: 10.3390/molecules20059183 http://doi.org/10.3390/molecules20059183 . Curcumin, inflammation, and chronic diseases: how are they linked? DS Hong , D Hui , E Bruera , 等 . MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study . Lancet Oncol , 2014 . 15 ( 6 ): 656 - 666 . 24746841 DOI: 10.1016/S1470-2045(14)70155-X http://doi.org/10.1016/S1470-2045(14)70155-X . MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study N Iizuka , K Miyamoto , S Hazama , 等 . Anticachectic effects of Coptidisrhizoma , an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6 . Cancer Lett , 2000 . 158 ( 1 ): 35 - 41 . 10940506 DOI: 10.1016/s0304-3835(00)00496-1 http://doi.org/10.1016/s0304-3835(00)00496-1 . Anticachectic effects of Coptidisrhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6 N Iizuka , S Hazama , K Yoshimura , 等 . Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma . Int J Cancer , 2002 . 99 ( 2 ): 286 - 291 . 11979446 DOI: 10.1002/ijc.10338 http://doi.org/10.1002/ijc.10338 . Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma F Ikegami , M Sumino , Y Fujii , 等 . Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use . Hum Exp Toxicol , 2006 . 25 ( 8 ): 481 - 494 . 16937920 DOI: 10.1191/0960327106het654oa http://doi.org/10.1191/0960327106het654oa . Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use M Iranshahi , R Rezaee , H Parhiz , 等 . Protective effects of flavonoids against microbes and toxins: the cases of hesperidin and hesperetin . Life Sci , 2015 . 137 125 - 132 . 26188593 DOI: 10.1016/j.lfs.2015.07.014 http://doi.org/10.1016/j.lfs.2015.07.014 . Protective effects of flavonoids against microbes and toxins: the cases of hesperidin and hesperetin SE Jang , JJ Jeong , SR Hyam , 等 . Anticolitic effect of the rhizome mixture of Anemarrhena asphodeloides and Coptidis chinensis (AC-mix) in mice . Biomol Ther , 2013 . 21 ( 5 ): 398 - 404 . DOI: 10.4062/biomolther.2013.048 http://doi.org/10.4062/biomolther.2013.048 . Anticolitic effect of the rhizome mixture of Anemarrhena asphodeloides and Coptidis chinensis (AC-mix) in mice JS Jeong , BH Ryu , JS Kim , 等 . Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial . Integr Cancer Ther , 2010 . 9 ( 4 ): 331 - 338 . 21059621 DOI: 10.1177/1534735410383170 http://doi.org/10.1177/1534735410383170 . Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial A Kim , M Im , JY Ma . Sosiho-tang ameliorates cachexia-related symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss . Oncol Rep , 2016 . 35 ( 3 ): 1841 - 1850 . 26718030 DOI: 10.3892/or.2015.4527 http://doi.org/10.3892/or.2015.4527 . Sosiho-tang ameliorates cachexia-related symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss A Kumar , Ekavali , K Chopra , 等 . Current knowledge and pharmacological profile of berberine: an update . Eur J Pharmacol , 2015 . 761 288 - 297 . 26092760 DOI: 10.1016/j.ejphar.2015.05.068 http://doi.org/10.1016/j.ejphar.2015.05.068 . Current knowledge and pharmacological profile of berberine: an update AJ Lee , HJ Lee , JD Kim , 等 . Changes of peripheral blood lymphocyte subtypes in patients with end stage cancer administered localized radiotherapy and bojungikki-tang . Evid Based Complement Alternat Med, 2014: 207613 , 2014 . DOI: 10.1155/2014/207613 http://doi.org/10.1155/2014/207613 . Changes of peripheral blood lymphocyte subtypes in patients with end stage cancer administered localized radiotherapy and bojungikki-tang K Lenk , S Palus , R Schur , 等 . Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model . J Cachexia Sarcopenia Muscle , 2013 . 4 ( 1 ): 63 - 69 . 22987245 DOI: 10.1007/s13539-012-0085-3 http://doi.org/10.1007/s13539-012-0085-3 . Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model W Lesniak , M Bala , R Jaeschke , 等 . Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome: a systematic review and meta-analysis . Pol Arch Med Wewn , 2008 . 118 ( 11 ): 636 - 644 . 19140567 . Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome: a systematic review and meta-analysis CQ Li , LC He , HY Dong , 等 . Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala Koidz . J Ethnopharmacol , 2007 . 114 ( 2 ): 212 - 217 . 17869038 DOI: 10.1016/j.jep.2007.08.002 http://doi.org/10.1016/j.jep.2007.08.002 . Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala Koidz CR Li , G Lin , Z Zuo . Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones . Biopharm Drug Dispos , 2011 . 32 ( 8 ): 427 - 445 . 21928297 DOI: 10.1002/bdd.771 http://doi.org/10.1002/bdd.771 . Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones XX Li , L Qu , YZ Dong , 等 . A review of recent research progress on the astragalus genus . Molecules , 2014 . 19 ( 11 ): 18850 - 18880 . 25407722 DOI: 10.3390/molecules191118850 http://doi.org/10.3390/molecules191118850 . A review of recent research progress on the astragalus genus CH Ma , MS Fan , YH Tang , 等 . Identification of major alkaloids and steroidal saponins in rat serum by HPLC-diode array detection-MS/MS following oral administration of Huangbai-Zhimu herb-pair extract . Biomed Chromatogr , 2008 . 22 ( 8 ): 835 - 850 . 18318017 DOI: 10.1002/bmc.1000 http://doi.org/10.1002/bmc.1000 . Identification of major alkaloids and steroidal saponins in rat serum by HPLC-diode array detection-MS/MS following oral administration of Huangbai-Zhimu herb-pair extract G Mantovani , A Macciò , E Massa , 等 . Managing cancer-related anorexia/cachexia . Drugs , 2001 . 61 ( 4 ): 499 - 514 . 11324680 DOI: 10.2165/00003495-200161040-00004 http://doi.org/10.2165/00003495-200161040-00004 . Managing cancer-related anorexia/cachexia T Matsumoto , MH Sakurai , H Kiyohara , 等 . Orally administered decoction of Kampo (Japanese herbal) medicine, “Juzen-Taiho-To” modulates cytokine secretion and induces NKT cells in mouse liver . Immunopharmacology , 2000 . 46 ( 2 ): 149 - 161 . 10647873 DOI: 10.1016/S0162-3109(99)00166-6 http://doi.org/10.1016/S0162-3109(99)00166-6 . Orally administered decoction of Kampo (Japanese herbal) medicine, “Juzen-Taiho-To” modulates cytokine secretion and induces NKT cells in mouse liver MC Mendes , GD Pimentel , FO Costa , 等 . Molecular and neuroendocrine mechanisms of cancer cachexia . J Endocrinol , 2015 . 226 ( 3 ): R29 - R43 . 26112046 DOI: 10.1530/JOE-15-0170 http://doi.org/10.1530/JOE-15-0170 . Molecular and neuroendocrine mechanisms of cancer cachexia S Mogami , T Hattori . Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: a systematic review . Evid Based Complement Alternat Med, 2014:519035 , 2014 . DOI: 10.1155/2014/519035 http://doi.org/10.1155/2014/519035 . Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: a systematic review RA Muluye , YH Bian , PN Alemu . Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review . J Tradit Complement Med , 2014 . 4 ( 2 ): 93 - 98 . 24860732 DOI: 10.4103/2225-4110.126635 http://doi.org/10.4103/2225-4110.126635 . Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review M Muscaritoli , SD Anker , J Argilés , 等 . Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics” . Clin Nutr , 2010 . 29 ( 2 ): 154 - 159 . 20060626 DOI: 10.1016/j.clnu.2009.12.004 http://doi.org/10.1016/j.clnu.2009.12.004 . Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics” M Nahata , Y Saegusa , C Sadakane , 等 . Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model . Neurogastroenterol Motil , 2014 . 26 ( 6 ): 821 - 831 . 24684160 DOI: 10.1111/nmo.12336 http://doi.org/10.1111/nmo.12336 . Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model O Naksuriya , S Okonogi , RM Schiffelers , 等 . Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment . Biomaterials , 2014 . 35 ( 10 ): 3365 - 3383 . 24439402 DOI: 10.1016/j.biomaterials.2013.12.090 http://doi.org/10.1016/j.biomaterials.2013.12.090 . Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment NM Neary , CJ Small , AM Wren , 等 . Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial . J Clin Endocrinol Metab , 2004 . 89 ( 6 ): 2832 - 2836 . 15181065 DOI: 10.1210/jc.2003-031768 http://doi.org/10.1210/jc.2003-031768 . Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial GL Niu , J Tan , JG Turner , 等 . Bing de ling, a Chinese herbal formula, stimulates multifaceted immunologic responses in mice . DNA Cell Biol , 2000 . 19 ( 8 ): 515 - 520 . 10975469 DOI: 10.1089/10445490050128449 http://doi.org/10.1089/10445490050128449 . Bing de ling, a Chinese herbal formula, stimulates multifaceted immunologic responses in mice K Ohbuchi , S Nishiumi , N Fujitsuka , 等 . Rikkunshito ameliorates cancer cachexia partly through elevation of glucarate in plasma . Evid Based Complement Alternat Med, 2015:871832 , 2015 . DOI: 10.1155/2015/871832 http://doi.org/10.1155/2015/871832 . Rikkunshito ameliorates cancer cachexia partly through elevation of glucarate in plasma H Parhiz , A Roohbakhsh , F Soltani , 等 . Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models . Phytother Res , 2015 . 29 ( 3 ): 323 - 331 . 25394264 DOI: 10.1002/ptr.5256 http://doi.org/10.1002/ptr.5256 . Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models A Pascual López , M Roqué I Figuls , G Urrutia Cuchi , 等 . Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome . J Pain Symptom Manage , 2004 . 27 ( 4 ): 360 - 369 . 15050664 DOI: 10.1016/j.jpainsymman.2003.09.007 http://doi.org/10.1016/j.jpainsymman.2003.09.007 . Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome MF Penet , ZM Bhujwalla . Cancer cachexia, recent advances, and future directions . Cancer J , 2015 . 21 ( 2 ): 117 - 122 . 25815852 DOI: 10.1097/PPO.0000000000000100 http://doi.org/10.1097/PPO.0000000000000100 . Cancer cachexia, recent advances, and future directions V Raghavendra , SK Kulkarni . Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT 2A receptor-mediated activation of HPA axis . Brain Res , 2000 . 860 ( 1-2 ): 112 - 118 . 10727629 DOI: 10.1016/S0006-8993(00)02031-X http://doi.org/10.1016/S0006-8993(00)02031-X . Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT2A receptor-mediated activation of HPA axis M Rattanasompattikul , MZ Molnar , ML Lee , 等 . Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial . J Cachexia Sarcopenia Muscle , 2013 . 4 ( 4 ): 247 - 257 . 24052226 DOI: 10.1007/s13539-013-0115-9 http://doi.org/10.1007/s13539-013-0115-9 . Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial WW Ru , DL Wang , YP Xu , 等 . Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.) . Drug Discov Ther , 2015 . 9 ( 1 ): 23 - 32 . 25788049 DOI: 10.5582/ddt.2015.01004 http://doi.org/10.5582/ddt.2015.01004 . Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.) Y Saegusa , H Takeda , S Muto , 等 . Decreased plasma ghrelin contributes to anorexia following novelty stress . Am J Physiol Endocrinol Metab , 2011 . 301 ( 4 ): E685 - E696 . 21712530 DOI: 10.1152/ajpendo.00121.2011 http://doi.org/10.1152/ajpendo.00121.2011 . Decreased plasma ghrelin contributes to anorexia following novelty stress Y Saegusa , T Hattori , M Nahata , 等 . A new strategy using rikkunshito to treat anorexia and gastrointestinal dysfunction . Evid Based Complement Alternat Med, 2015: 364260 , 2015 . DOI: 10.1155/2015/364260 http://doi.org/10.1155/2015/364260 . A new strategy using rikkunshito to treat anorexia and gastrointestinal dysfunction I Saiki . A Kampo medicine “Juzen-taiho-to”: prevention of malignant progression and metastasis of tumor cells and the mechanism of action . Biol Pharm Bull , 2000 . 23 ( 6 ): 677 - 688 . 10864015 DOI: 10.1248/bpb.23.677 http://doi.org/10.1248/bpb.23.677 . A Kampo medicine “Juzen-taiho-to”: prevention of malignant progression and metastasis of tumor cells and the mechanism of action MK Shanmugam , G Rane , MM Kanchi , 等 . The multifaceted role of curcumin in cancer prevention and treatment . Molecules , 2015 . 20 ( 2 ): 2728 - 2769 . 25665066 DOI: 10.3390/molecules20022728 http://doi.org/10.3390/molecules20022728 . The multifaceted role of curcumin in cancer prevention and treatment F Strasser , TA Lutz , MT Maeder , 等 . Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study . Br J Cancer , 2008 . 98 ( 2 ): 300 - 308 . 18182992 DOI: 10.1038/sj.bjc.6604148 http://doi.org/10.1038/sj.bjc.6604148 . Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study Y Takahashi , Y Soejima , A Kumagai , 等 . Japanese herbal medicines shosaikoto, inchinkoto, and juzentaihoto inhibit high-fat diet-induced nonalcoholic steatohepatitis in db/db mice . Pathol Int , 2014 . 64 ( 10 ): 490 - 498 . 25229199 DOI: 10.1111/pin.12199 http://doi.org/10.1111/pin.12199 . Japanese herbal medicines shosaikoto, inchinkoto, and juzentaihoto inhibit high-fat diet-induced nonalcoholic steatohepatitis in db/db mice H Takeda , C Sadakane , T Hattori , 等 . Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism . Gastroenterology , 2008 . 134 ( 7 ): 2004 - 2013 . 18439428 DOI: 10.1053/j.gastro.2008.02.078 http://doi.org/10.1053/j.gastro.2008.02.078 . Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism H Takeda , S Muto , T Hattori , 等 . Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition . Endocrinology , 2010 . 151 ( 1 ): 244 - 252 . 19906817 DOI: 10.1210/en.2009-0633 http://doi.org/10.1210/en.2009-0633 . Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition YH Tang , ZL Sun , MS Fan , 等 . Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice . Planta Med , 2012 . 78 ( 1 ): 18 - 23 . 22002851 DOI: 10.1055/s-0031-1280268 http://doi.org/10.1055/s-0031-1280268 . Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice M Tatsuta , H Iishi . Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients . Aliment Pharmacol Ther , 1993 . 7 ( 4 ): 459 - 462 . 8218760 DOI: 10.1111/j.1365-2036.1993.tb00120.x http://doi.org/10.1111/j.1365-2036.1993.tb00120.x . Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients K Terawaki , Y Sawada , Y Kashiwase , 等 . New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line . Am J Physiol Endocrinol Metab , 2014 . 306 ( 4 ): E373 - E387 . 24347053 DOI: 10.1152/ajpendo.00116.2013 http://doi.org/10.1152/ajpendo.00116.2013 . New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line SCCM Teunissen , W Wesker , C Kruitwagen , 等 . Symptom prevalence in patients with incurable cancer: a systematic review . J Pain Symptom Manage , 2007 . 34 ( 1 ): 94 - 104 . 17509812 DOI: 10.1016/j.jpainsymman.2006.10.015 http://doi.org/10.1016/j.jpainsymman.2006.10.015 . Symptom prevalence in patients with incurable cancer: a systematic review MJ Tisdale . Biology of cachexia . J Natl Cancer Inst , 1997 . 89 ( 23 ): 1763 - 1773 . 9392617 DOI: 10.1093/jnci/89.23.1763 http://doi.org/10.1093/jnci/89.23.1763 . Biology of cachexia S von Haehling , SD Anker . Treatment of cachexia: an overview of recent developments . Int J Cardiol , 2015 . 184 736 - 742 . 25804188 DOI: 10.1016/j.ijcard.2014.10.026 http://doi.org/10.1016/j.ijcard.2014.10.026 . Treatment of cachexia: an overview of recent developments H Wang , YL Chan , TL Li , 等 . Improving cachectic symptoms and immune strength of tumour-bearing mice in chemotherapy by a combination of Scutellaria baicalensis and Qing-Shu-Yi-Qi-Tang . Eur J Cancer , 2012 . 48 ( 7 ): 1074 - 1084 . 21782419 DOI: 10.1016/j.ejca.2011.06.048 http://doi.org/10.1016/j.ejca.2011.06.048 . Improving cachectic symptoms and immune strength of tumour-bearing mice in chemotherapy by a combination of Scutellaria baicalensis and Qing-Shu-Yi-Qi-Tang N Wang , HY Tan , L Li , 等 . Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives . J Ethnopharmacol , 2015 . 176 35 - 48 . 26494507 DOI: 10.1016/j.jep.2015.10.028 http://doi.org/10.1016/j.jep.2015.10.028 . Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives HS Wen , X Li , YZ Cao , 等 . Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide . Chemotherapy , 2012 . 58 ( 6 ): 461 - 467 . 23406994 DOI: 10.1159/000346446 http://doi.org/10.1159/000346446 . Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide X Wu , HJ Zhang , JMM Salmani , 等 . Advances of wogonin, an extract from Scutellaria baicalensis , for the treatment of multiple tumors . OncoTargets Ther , 2016 . 9 2935 - 2943 . DOI: 10.2147/OTT.S105586 http://doi.org/10.2147/OTT.S105586 . Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors Q Xu , JG Brabham , SM Zhang , 等 . Chinese herbal formula, Bing De Ling, enhances antitumor effects and ameliorates weight loss induced by 5-fluorouracil in the mouse CT26 tumor model . DNA Cell Biol , 2005 . 24 ( 7 ): 470 - 475 . 16008516 DOI: 10.1089/dna.2005.24.470 http://doi.org/10.1089/dna.2005.24.470 . Chinese herbal formula, Bing De Ling, enhances antitumor effects and ameliorates weight loss induced by 5-fluorouracil in the mouse CT26 tumor model S Yae , F Takahashi , T Yae , 等 . Hochuekkito (TJ-41), a Kampo formula, ameliorates cachexia induced by colon 26 adenocarcinoma in mice . Evid Based Complement Alternat Med, 2012:976926 , 2012 . DOI: 10.1155/2012/976926 http://doi.org/10.1155/2012/976926 . Hochuekkito (TJ-41), a Kampo formula, ameliorates cachexia induced by colon 26 adenocarcinoma in mice C Yamada , Y Saegusa , K Nakagawa , 等 . Rikkunshito, a Japanese Kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model . BioMed Res Int, 2013:792940 , 2013 . DOI: 10.1155/2013/792940 http://doi.org/10.1155/2013/792940 . Rikkunshito, a Japanese Kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model S Yanagihara , H Kobayashi , H Tamiya , 等 . Protective effect of hochuekkito , a Kampo prescription, against ultraviolet B irradiation-induced skin damage in hairless mice . J Dermatol , 2013 . 40 ( 3 ): 201 - 206 . 23294358 DOI: 10.1111/1346-8138.12050 http://doi.org/10.1111/1346-8138.12050 . Protective effect of hochuekkito, a Kampo prescription, against ultraviolet B irradiation-induced skin damage in hairless mice SH Yang , TI Kao , BL Chiang , 等 . Immune-modulatory effects of Bu-Zhong-Yi-Qi-Tang in ovalbumin-induced murine model of allergic asthma . PLoS ONE , 2015 . 10 ( 6 ): e0127636 26035827 DOI: 10.1371/journal.pone.0127636 http://doi.org/10.1371/journal.pone.0127636 . Immune-modulatory effects of Bu-Zhong-Yi-Qi-Tang in ovalbumin-induced murine model of allergic asthma HT Yao , YW Chang , N Uramaru , 等 . Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats . J Ethnopharmacol , 2012 . 142 ( 1 ): 121 - 128 . 22564357 DOI: 10.1016/j.jep.2012.04.024 http://doi.org/10.1016/j.jep.2012.04.024 . Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats S Yennurajalingam , JS Willey , JL Palmer , 等 . The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study . J Palliat Med , 2012 . 15 ( 10 ): 1059 - 1064 . 22880820 DOI: 10.1089/jpm.2012.0146 http://doi.org/10.1089/jpm.2012.0146 . The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study JB Zhang , PW Zhuang , Y Wang , 等 . Reversal of muscle atrophy by Zhimu-Huangbai herb-pair via Akt/mTOR/FoxO3 signal pathway in streptozotocin-induced diabetic mice . PLoS ONE , 2014 . 9 ( 6 ): e100918 24968071 DOI: 10.1371/journal.pone.0100918 http://doi.org/10.1371/journal.pone.0100918 . Reversal of muscle atrophy by Zhimu-Huangbai herb-pair via Akt/mTOR/FoxO3 signal pathway in streptozotocin-induced diabetic mice Y Zhang , H Dong , Z Li , 等 . Bing De Ling, a Chinese herbal formula, inhibits cancer cells growth via p53 . Front Biosci , 2010 . 2 221 - 230 . . Bing De Ling, a Chinese herbal formula, inhibits cancer cells growth via p53 PW Zhuang , JB Zhang , Y Wang , 等 . Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1/Akt and autophagy signal in cancer cachexia . Support Care Cancer , 2016 . 24 ( 3 ): 1189 - 1198 . 26280404 DOI: 10.1007/s00520-015-2892-5 http://doi.org/10.1007/s00520-015-2892-5 . Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1/Akt and autophagy signal in cancer cachexia Compliance with ethics guidelines Bongki PARK, Sooseong YOU, William C. S. CHO, Jun-Yong CHOI, and Myeong Soo LEE declare that they have no conflict of interests. This article does not contain any studies with human or animal subjects performed by any of the authors, and does not need to obtain the Institutional Review Board of human or animals. 10.1631/jzus.B1800171 Project supported by the Korea Institute of Oriental Medicine (Nos. K18041 (SSY) and K18043 (MSL)) and the Basic Science Research Program Through the National Research Foundation (NRF) of Korea (Nos. NRF-2015R1D1A1A02062410 (SSY) and NRF-2017R1A2B 4005357 (JYC)) 2018-03-20 2018-08-20 2022-01-05 Copyright © Zhejiang University and Springer-Verlag GmbH Germany, part of Springer Nature 2019 2019 Journal of Zhejiang University-SCIENCE B (Biomedicine and Biotechnology) 01 20